HH&L Acquisition Co. Merges With DiaCarta to Create a Public Company
October 14, 2022
DiaCarta entered into a definitive business combination agreement with SPAC HH&L Acquisition Co. to become a publicly listed company. The transaction is expected to provide DiaCarta access to approximately $414 million held in HH&L’s IPO trust and is expected to close in the first quarter of 2023.
- Buyers
- HH&L Acquisition Co.
- Targets
- DiaCarta, Ltd, DiaCarta, Inc.
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Mana Capital Acquisition Corp. Completes Business Combination with Cardio Diagnostics (Cardio Diagnostics Holdings, Inc.)
October 26, 2022
Biotechnology
Mana Capital Acquisition Corp. completed its business combination with Cardio Diagnostics, resulting in Cardio Diagnostics Holdings, Inc. being listed on Nasdaq under ticker CDIO (common stock) and CDIOW (warrants). The deal had been supported by a previously announced definitive merger agreement dated May 27, 2022 and required multiple extensions to complete before closing.
-
Healthcare AI Acquisition Corp. to Take Leading Group Public via Business Combination
August 15, 2024
Financial Services
Leading Group Limited, a China-based digital insurance broker and insurance channel specialist, entered into a definitive business combination agreement with Healthcare AI Acquisition Corp. (NASDAQ: HAIA). The deal will result in a series of merger transactions where Leading Group will be the surviving entity and the combined company is intended to be listed on Nasdaq.
-
Hyperfine and Liminal Sciences to Combine via HealthCor Catalio SPAC Business Combination
July 8, 2021
Healthcare Services
Hyperfine and Liminal Sciences entered into a definitive business combination agreement with healthcare-focused SPAC HealthCor Catalio Acquisition Corp. Upon closing, HealthCor Catalio will be renamed as Hyperfine, and the combined company is expected to trade on Nasdaq under ticker HYPR. The transaction is valued at approximately $580 million enterprise value and includes a $126 million PIPE (with institutional participation). The companies expect the deal to close in the fourth quarter of 2021, subject to customary approvals and conditions.
-
HDL Capital (formerly WD Capital Markets) Management Buyout
March 31, 2025
Financial Services
The leadership team of WD Capital Markets Inc. completed a management buyout, acquiring 100% of the company and relaunching it as HDL Capital Inc., effective March 31, 2025. HDL will continue providing M&A advisory and transaction services to small- and mid-market clients from its Toronto base and expects to expand its team and Transaction Services practice.
-
Carta Acquires ListAlpha to Launch Carta CRM
March 6, 2026
Cloud & SaaS
Carta, the ERP platform for private capital, acquired ListAlpha, an AI-powered CRM and relationship intelligence platform. The acquisition launches Carta CRM and unifies front-office relationship management with Carta’s back-office fund administration to support deal sourcing, fundraising, and portfolio workflows in a single system.
-
Carousel Capital Recapitalizes Legacy Data Access with Cadrillion Capital
July 20, 2021
Healthcare Services
Carousel Capital has partnered with Cadrillion Capital to recapitalize Legacy Data Access, LLC, a Charlotte-based provider of healthcare data lifecycle management and legacy EHR/EMR archiving solutions. The recapitalization will provide capital to support LDA's growth and platform development, with Carousel funding the transaction from its sixth investment fund.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.